Lack of association between interleukin-8-251 t>a polymorphism and colorectal cancer risk: A meta-analysis based on 3,019 cases and 3,984 controlsll

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5075-5079

  Hu, Li Xia ^a   Du, Ying Ying ^a   Zhang, Ying ^a   Pan, Yue Yin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Interleukin 8; Meta analysis; Polymorphism

Indexed keywords

EID: 84874003139     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5075     Document Type: Article

References (36)

1. Abuli A, Bessa X, Gonzalez JR, et al (2010). Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. Gastroenterology, 139, 788-96, 96 e781-6.
2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
3. Bendre MS, Gaddy-Kurten D, Mon-Foote T, et al (2002). Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res, 62, 5571-9.
4. Cacev T, Radosevic S, Krizanac S, et al (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis, 29, 1572-80.
5. Cheah PY (2009). Recent advances in colorectal cancer genetics and diagnostics. Crit Rev Oncol Hematol, 69, 45-55.
6. DerSimonian R and Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
7. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Glade MJ (1999). Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition, 15, 523-6.
9. Gunter MJ, Canzian F, Landi S, et al. (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev, 15, 1126-31.
10. Haber M (1981). Exact significance levels of goodness-of-fit tests for the Hardy-Weinberg equilibrium. Hum Hered, 31, 161-6.
11. Harada A, Sekido N, Akahoshi T, et al (1994). Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol, 56, 559-64.
12. Heinzmann A, Ahlert I, Kurz T, et al (2004). Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol, 114, 671-6.
13. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
14. Jemal A, Siegel R, Xu J, et al. (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
15. Kavvoura FK, Ioannidis JP (2008). Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet, 123, 1-14.
16. Kitadai Y, Haruma K, Mukaida N, et al (2000). Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res, 6, 2735-40.
17. Kury S, Buecher B, Robiou-du-Pont S, et al (2008). Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer, 8, 326.
18. Landi S, Moreno V, Gioia-Patricola L, et al (2003). Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res, 63, 3560-6.
19. Li A, Dubey S, Varney ML, et al (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 170, 3369-76.
20. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
21. Mustapha MA, Shahpudin SN, Aziz AA, et al (2012). Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol, 18, 2668-73.
22. Ohyauchi M, Imatani A, Yonechi M, et al (2005). The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut, 54, 330-5.
23. Potter JD (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-32.
24. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.
25. Taguchi A, Ohmiya N, Shirai K, et al (2005). Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev, 14, 2487-93.
26. Tenesa A, Farrington SM, Prendergast JG, et al (2008). Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet, 40, 631-7.
27. Theodoropoulos G, Papaconstantinou I, Felekouras E, et al (2006). Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol, 12, 5037-43.
28. Tomlinson IP, Webb E, Carvajal-Carmona L, et al (2008). A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet, 40, 623-30.
29. Tsilidis KK, Helzlsouer KJ, Smith MW, et al (2009). Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control, 20, 1739-51.
30. van Aken BE, Reitsma PH and Rosendaal FR (2002). Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol, 116, 173-7.
31. Vogel U, Christensen J, Dybdahl M, et al (2007). Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res, 624, 88-100.
32. Walczak A, Przybylowska K, Dziki L, et al (2012). The lL-8 and IL-13 Gene Polymorphisms in Inflammatory Bowel Disease and Colorectal Cancer. DNA Cell Biol, 31, 1431-8.
33. Wang N, Zhou R, Wang C, et al (2012). -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep, 39, 2831-41.
34. Wei YS, Lan Y, Tang RG, et al (2007). Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol, 125, 309-17.
35. Wilkening S, Tavelin B, Canzian F, et al (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis, 29, 1202-6.
36. Xie K (2001). Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev, 12, 375-91.